Truffle Capital announces the first closing of its new BioMedTech venture fund, dedicated to medical devices and biotechnology – Truffle

Follow us

Press Release

Truffle Capital announces the first closing of its new BioMedTech venture fund, dedicated to medical devices and biotechnology

January 10, 2018

Download PDF

Also to be discovered

May 17, 2017

Truffle Capital announces the close of Symetis acquisition for $435 million by Boston Scientific

May 31, 2016

"Growing sustainably à la française", by Philippe Pouletty, Partner at Truffle Capital

April 29, 2016

French software boom built on SaaS